386 related articles for article (PubMed ID: 25688860)
1. Platelet surface-associated activation and secretion-mediated inhibition of coagulation factor XII.
Zakharova NV; Artemenko EO; Podoplelova NA; Sveshnikova AN; Demina IA; Ataullakhanov FI; Panteleev MA
PLoS One; 2015; 10(2):e0116665. PubMed ID: 25688860
[TBL] [Abstract][Full Text] [Related]
2. Activated human platelets induce factor XIIa-mediated contact activation.
Bäck J; Sanchez J; Elgue G; Ekdahl KN; Nilsson B
Biochem Biophys Res Commun; 2010 Jan; 391(1):11-7. PubMed ID: 19878657
[TBL] [Abstract][Full Text] [Related]
3. Competitive-protein adsorption in contact activation of blood factor XII.
Zhuo R; Siedlecki CA; Vogler EA
Biomaterials; 2007 Oct; 28(30):4355-69. PubMed ID: 17644174
[TBL] [Abstract][Full Text] [Related]
4. Inhibiting the intrinsic pathway of coagulation with a factor XII-targeting RNA aptamer.
Woodruff RS; Xu Y; Layzer J; Wu W; Ogletree ML; Sullenger BA
J Thromb Haemost; 2013 Jul; 11(7):1364-73. PubMed ID: 23692437
[TBL] [Abstract][Full Text] [Related]
5. Studies of adsorption, activation, and inhibition of factor XII on immobilized heparin.
Sanchez J; Elgue G; Riesenfeld J; Olsson P
Thromb Res; 1998 Jan; 89(1):41-50. PubMed ID: 9610759
[TBL] [Abstract][Full Text] [Related]
6. Identification of the factor XII contact activation site enables sensitive coagulation diagnostics.
Heestermans M; Naudin C; Mailer RK; Konrath S; Klaetschke K; Jämsä A; Frye M; Deppermann C; Pula G; Kuta P; Friese MA; Gelderblom M; Sickmann A; Preston RJS; Nofer JR; Rose-John S; Butler LM; Salomon O; Stavrou EX; Renné T
Nat Commun; 2021 Sep; 12(1):5596. PubMed ID: 34552086
[TBL] [Abstract][Full Text] [Related]
7. Binding of activated Factor XII to endothelial cells affects its inactivation by the C1-esterase inhibitor.
Schousboe I
Eur J Biochem; 2003 Jan; 270(1):111-8. PubMed ID: 12492481
[TBL] [Abstract][Full Text] [Related]
8. Factor XII Activation Promotes Platelet Consumption in the Presence of Bacterial-Type Long-Chain Polyphosphate In Vitro and In Vivo.
Zilberman-Rudenko J; Reitsma SE; Puy C; Rigg RA; Smith SA; Tucker EI; Silasi R; Merkulova A; McCrae KR; Maas C; Urbanus RT; Gailani D; Morrissey JH; Gruber A; Lupu F; Schmaier AH; McCarty OJT
Arterioscler Thromb Vasc Biol; 2018 Aug; 38(8):1748-1760. PubMed ID: 30354195
[TBL] [Abstract][Full Text] [Related]
9. The second exon-encoded factor XII region is involved in the interaction of factor XII with factor XI and does not contribute to the binding site for negatively charged surfaces.
Citarella F; Fedele G; Roem D; Fantoni A; Hack CE
Blood; 1998 Dec; 92(11):4198-206. PubMed ID: 9834224
[TBL] [Abstract][Full Text] [Related]
10. Enzymes produced by autoactivation of blood factor XII in buffer: A contribution from the Hematology at Biomaterial Interfaces Research Group.
Golas A; Pitakjakpipop H; Rahn MS; Siedlecki CA; Vogler EA
Biomaterials; 2015 Jan; 37():1-12. PubMed ID: 25443791
[TBL] [Abstract][Full Text] [Related]
11. Control of contact activation on end-point immobilized heparin: the role of antithrombin and the specific antithrombin-binding sequence.
Sanchez J; Elgue G; Riesenfeld J; Olsson P
J Biomed Mater Res; 1995 May; 29(5):655-61. PubMed ID: 7622551
[TBL] [Abstract][Full Text] [Related]
12. Cationic zinc is required for factor XII recruitment and activation by stimulated platelets and for thrombus formation in vivo.
Chaudhry SA; Serrata M; Tomczak L; Higgins S; Ryu J; Laprise D; Enjyoji K; Bekendam R; Kaushik V; Flaumenhaft R; Bendapudi PK
J Thromb Haemost; 2020 Sep; 18(9):2318-2328. PubMed ID: 32542960
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological regulation of factor XII activation may be a new target to control pathological coagulation.
Schousboe I
Biochem Pharmacol; 2008 Mar; 75(5):1007-13. PubMed ID: 17996217
[TBL] [Abstract][Full Text] [Related]
14. Synthetic anionic surfaces can replace microparticles in stimulating burst coagulation of blood plasma.
Contreras-García A; D'Elía NL; Desgagné M; Lafantaisie-Favreau CH; Rivard GE; Ruiz JC; Wertheimer MR; Messina P; Hoemann CD
Colloids Surf B Biointerfaces; 2019 Mar; 175():596-605. PubMed ID: 30580150
[TBL] [Abstract][Full Text] [Related]
15. Factor XII truncation accelerates activation in solution.
de Maat S; Clark CC; Boertien M; Parr N; Sanrattana W; Hofman ZLM; Maas C
J Thromb Haemost; 2019 Jan; 17(1):183-194. PubMed ID: 30394658
[TBL] [Abstract][Full Text] [Related]
16. Factor XII as a Therapeutic Target in Thromboembolic and Inflammatory Diseases.
Nickel KF; Long AT; Fuchs TA; Butler LM; Renné T
Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):13-20. PubMed ID: 27834692
[TBL] [Abstract][Full Text] [Related]
17. Immobilized transition metal ions stimulate contact activation and drive factor XII-mediated coagulation.
Mutch NJ; Waters EK; Morrissey JH
J Thromb Haemost; 2012 Oct; 10(10):2108-15. PubMed ID: 22905925
[TBL] [Abstract][Full Text] [Related]
18. Laminin promotes coagulation and thrombus formation in a factor XII-dependent manner.
White-Adams TC; Berny MA; Patel IA; Tucker EI; Gailani D; Gruber A; McCarty OJ
J Thromb Haemost; 2010 Jun; 8(6):1295-301. PubMed ID: 20796202
[TBL] [Abstract][Full Text] [Related]
19. Mathematical modeling of material-induced blood plasma coagulation.
Guo Z; Bussard KM; Chatterjee K; Miller R; Vogler EA; Siedlecki CA
Biomaterials; 2006 Feb; 27(5):796-806. PubMed ID: 16099033
[TBL] [Abstract][Full Text] [Related]
20. Surface dependent contact activation of factor XII and blood plasma coagulation induced by mixed thiol surfaces.
Bauer JW; Xu LC; Vogler EA; Siedlecki CA
Biointerphases; 2017 May; 12(2):02D410. PubMed ID: 28514863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
